7thirty Capital

BDSA provides comprehensive cannabis market intelligence, including sales tracking, market forecasts, and consumer insights to help businesses navigate the evolving cannabis industry.

PathogenDx is a biotechnology innovator based in Tucson, Arizona, developing diagnostic solutions to address viral, bacterial and fungal infection or contamination. The company has reinvented DNA-based testing to identify pathogens faster and easier, driving greater safety and business optimization in fields ranging from healthcare to agriculture to dairy farming.

Weller offers functional beverages, including CBD-infused sparkling water and immunity drinks, designed to promote wellness and vitality.

Flourish Software provides award-winning seed-to-sale and ERP software specifically designed for the cannabis industry, offering solutions for cultivation management, manufacturing, distribution, retail point of sale, and B2B eCommerce.

DeepGreen is focused on developing an embedded artificial intelligence model that combines sovereignty, trust, and frugality, aiming to optimize and deploy embedded AI applications across various industries.

Apex Trading is a wholesale cannabis platform that simplifies inventory management, distribution, and sales for cannabis companies.

Trym provides software solutions designed specifically for commercial cannabis growers, focusing on compliance, crop management, and team efficiency.

Building the training layer underneath the space economy — NASA-grade astronaut training, education, and simulation — delivered as a commercial, asset-light platform based in the UAE.

Lendica is an embedded finance platform that provides a full suite of funding solutions, including AI-powered underwriting and invoice automation, to help businesses manage their accounts receivable and improve cash flow.

KelSie Biotech specializes in formulating and delivering sensitive Active Pharmaceutical Ingredients (APIs) using its patented Carbon-Dioxide Assisted Nebulization Bubble Drying (CAN-BD) process. The company offers a range of services including formulation development, testing, licensing, trial design, and manufacturing.

Veteran VC and mountain guide-led firm focused on Colorado and the Mid-Atlantic, offering hands-on pre-investment partnership and local sourcing expertise while prioritizing realized exits over paper markups.

Early-stage investor focused on Black, Latinx, and Indigenous founders, offering hands-on support in product, tech-stack strategy, and team structure.

Left Lane Capital is a $2.2-2.5B venture fund that spun out from Insight Partners specifically to invest in consumer internet and SMB tech companies during their breakout growth phase, focusing on businesses where customers develop enduring relationships lasting 5-10+ years rather than boom-or-bust models. The fund differentiates itself by embracing complex, regulation-heavy markets that other VCs avoid and conducting unusually deep transaction-level data analysis to underwrite consumer durability before investing $5-50M initial checks globally.

Stealthy investor across frontier sectors (space, biotech, AI) making sub-$500K average checks into technically complex startups with exceptional defensibility and operational guidance from GP Rob Ness's 2% Rule.

Seed-stage investor focused on climate and human health that backs founders whose mission is core to product. Wireframe Ventures is built around a people-product-purpose thesis that only backs founders whose mission to improve the health of people and planet is inseparable from their commercial product. The fund has demonstrated strong performance by taking early technical risk in deeptech, biotech, and energy companies, with Fund I yielding two unicorns, two exits, and approximately 70% of portfolio companies raising institutional Series A rounds within 15 months.